Stock MBRX MOLECULIN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Moleculin Biotech, Inc.

Equities

MBRX

US60855D3098

Delayed Nasdaq
Other stock markets
 11:46:40 2024-05-13 am EDT 		5-day change 1st Jan Change
4.71 USD -1.05% Intraday chart for Moleculin Biotech, Inc. -6.55% -63.42%
May. 10 Moleculin Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 07 Transcript : Moleculin Biotech, Inc. - Special Call
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOLECULIN BIOTECH, INC. Stock Moleculin Biotech, Inc.
 10.6M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. MBRX Stock
  4. Charts Moleculin Biotech, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW